Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

Click for more information

0.00%

3.9¢ g medical innovations holdings limited

GMVD Nasdaq, page-378

First 378 Last

Share
Profile

Follow
61212305

1,174 Posts.

117

17/06/22

15:09

Post #: 62059428
Share

Originally posted by IronChef: ↑

There's nothing wrong with shorting a stock.
What's actually evil is a company telling lies in official stock market announcements about revenue or purchase orders.
Or printing shares for Board members, to reward Board 'performance' -- based on these fake revenue announcements.
Or lying about the progress and intent of NMPA applications.
Or lying about delisting.
Or manipulating the SP by buying its own shares.
Basically, Yacov's CV.
Meanwhile, the pump squad on Nasdaq, with no clue or interest in the company's fundamentals, is excited about an SP that's hovering at 1 Australian cent, because it *might* get to 1.5 Australian cents. The holy grail is 1/5 of what they IPO'ed at, only 12 months ago.
Yacov has finally found a way to set the bar so low, even he might achieve it. Temporarily.
Yet even with 60M shares traded in one day, the SP couldn't get close to US$1.
There's a limit to how much even a dedicated pump and dump squad can achieve.
So are they at 30 business days below $1 yet?
When does Yacov's charade end?

Expand

100%. The bar has intentionally been set low.

US$1 is the ASX equivalent of 1.55c AUD

$2 is 3.1c
$3 is 4.6c
$4 is 6.2c
$5 is 7.7c

Delisting was at 3.9c which is around
US$2.55.

Happy Clapper time.

Last edited by 61212305: 17/06/22

GMV Price at posting: 3.9¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 450 more messages in this thread...

First 378 Last

Add GMV (ASX) to my watchlist